<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR68">
 <label>68.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Diurno</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Numis</surname>
    <given-names>FG</given-names>
   </name>
   <name>
    <surname>Porta</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Cirillo</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Maddaluno</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Ragozzino</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience</article-title>
  <source>Eur Rev Med Pharmacol Sci</source>
  <year>2020</year>
  <volume>24</volume>
  <fpage>4040</fpage>
  <lpage>4047</lpage>
  <?supplied-pmid 32329881?>
  <pub-id pub-id-type="pmid">32329881</pub-id>
 </element-citation>
</ref>
